Targeting Amyloid-ß Oligomers With Investigational Alzheimer Disease Therapy Valiltramiprosate
Written by
Neurology Live
Published
0
comments
0
min
Sam Gandy, MD, PhD, director of the Center for Cognitive Health at the Icahn School of Medicine at Mount Sinai, discussed his presentation on detecting toxic amyloid-β oligomers and their role in AD pathology at AAIC 2025.